Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

GT Biopharma Inc (GTBP)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 96,839
  • Shares Outstanding, K 47,470
  • Annual Sales, $ 0 K
  • Annual Income, $ -143,250 K
  • 36-Month Beta -3.16
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 0.39
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1,799.15
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 06/22/18
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
1.3700 +49.64%
on 05/31/18
2.7900 -26.52%
on 06/07/18
+0.4000 (+24.24%)
since 05/22/18
3-Month
1.1900 +72.27%
on 05/04/18
2.7900 -26.52%
on 06/07/18
+0.3900 (+23.49%)
since 03/22/18
52-Week
1.1900 +72.27%
on 05/04/18
36.9000 -94.44%
on 08/16/17
-2.0000 (-49.38%)
since 06/22/17

Most Recent Stories

More News
GT Biopharma Announces Preliminary Clinical Results From Interim Review of Phase 1/2 Clinical Trial of OXS-1550, its Bi-Specific Antibody Drug Conjugate

LOS ANGELES , June 11, 2018 /PRNewswire/ --

GTBP : 2.0500 (+0.49%)
Seasoned Financial Executive Federica O'Brien Joins GT Biopharma's Board of Directors

LOS ANGELES , April 26, 2018 /PRNewswire/ --

GTBP : 2.0500 (+0.49%)
These Biotech Stocks Have a Strong Green Close on Friday

CORAL GABLES, FL / ACCESSWIRE / March 29, 2018 / The biotechnology industry continued to recover on Thursday. The market itself had one of its most volatile weeks yet as the first quarter of 2018 came...

GALT : 7.67 (-0.52%)
GTBP : 2.0500 (+0.49%)
CELGZ : 0.39 (-2.50%)
JUNO : 86.96 (+0.10%)
GT Biopharma Inc. Announces >50% Enrollment in Proof-Of-Concept Clinical Trial For Its Novel Treatment For Motion Sickness

WASHINGTON , March 29, 2018 /PRNewswire/ --

GTBP : 2.0500 (+0.49%)
2 Health Sector Stocks To Watch As Biotech Market Rallies

CORAL GABLES, FL / ACCESSWIRE / March 27, 2018 / The biotechnology industry continues to recover this week. After having stumbled last week, along with the overall market, benchmarks based on the NASDAQ...

EKSO : 1.69 (-1.74%)
GTBP : 2.0500 (+0.49%)
2 Biotech Stocks To Watch After Positive Pre Market News

CORAL GABLES, FL / ACCESSWIRE / March 26, 2018 / Last week, the markets saw a major pullback amid fears of potential trade wars. But heading into Monday's opening bell, optimism is much more prevalent....

AKER : 0.38 (-2.56%)
GTBP : 2.0500 (+0.49%)
GT Biopharma, Inc. Announces Additional Positive Data From Its Phase 1 Clinical Trial For Myasthenia Gravis and Potential for Acceleration of the Start of Its Phase 2 Trial

GTBP : 2.0500 (+0.49%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market and OTCQB® Venture Market presenting companies...

KSHB : 5.1100 (+0.29%)
EVLLF : 0.7640 (-6.49%)
OPRX : 10.40 (+0.29%)
DMIFF : 0.2900 (-3.33%)
CORVF : 1.7697 (+1.71%)
IMPZY : 1.6000 (unch)
CHPE : 18.1250 (+0.14%)
CBWTF : 0.9600 (-4.81%)
ATMS : 1.0101 (unch)
RSSS : 1.7000 (-0.58%)
FSSN : 0.1700 (+3.03%)
MSRT : 0.2500 (-1.96%)
GPVRF : 0.5192 (+0.44%)
QBIO : 3.4500 (-0.29%)
SNYR : 0.3350 (+4.69%)
ACBFF : 7.5300 (-4.32%)
CVSI : 1.6300 (+17.27%)
RSASF : 0.3020 (-22.44%)
COSM : 6.1500 (+8.85%)
GRWG : 4.2700 (-0.47%)
GTBP : 2.0500 (+0.49%)
ZYXI : 3.1000 (-6.06%)
PURE : 0.7000 (+16.67%)
CXDO : 2.7500 (+3.77%)
BCTXF : 0.1300 (+1.56%)
TAOIF : 0.3082 (+3.81%)
BNOEF : 0.3950 (+3.03%)
NMKEF : 0.6820 (+7.69%)
CNNRF : 4.0300 (-0.98%)
ZEST : 1.4500 (-3.33%)
HEOFF : 0.9007 (-2.43%)
ITHUF : 5.6246 (-2.18%)
COTQF : 0.3740 (-4.30%)
OTCM : 27.8100 (-3.34%)
DCTH : 2.8000 (+1.82%)
AEYE : 0.2310 (+0.43%)
VFFIF : 5.6657 (-1.64%)
TITXF : 0.1930 (-1.03%)
NMGRF : 0.2313 (+3.63%)
GLDLF : 0.6800 (+1.49%)
SNNVF : 5.9500 (+0.90%)
IWSY : 1.3100 (-0.76%)
ARTH : 0.4640 (+1.98%)
IRNC : 0.7000 (-23.08%)
PNGZF : 0.1650 (+13.79%)
NTSFF : 0.9154 (-1.71%)
OTCQX And OTCQB Companies to Present At 2018 ROTH Conference

NEW YORK , March 8, 2018 /PRNewswire/ -- OTC Markets Group Inc.  (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, today unveiled the list of OTCQX® Best Market...

EVLLF : 0.7640 (-6.49%)
KSHB : 5.1100 (+0.29%)
DMIFF : 0.2900 (-3.33%)
OPRX : 10.40 (+0.29%)
CORVF : 1.7697 (+1.71%)
IMPZY : 1.6000 (unch)
CBWTF : 0.9600 (-4.81%)
CHPE : 18.1250 (+0.14%)
ATMS : 1.0101 (unch)
RSSS : 1.7000 (-0.58%)
FSSN : 0.1700 (+3.03%)
MSRT : 0.2500 (-1.96%)
GPVRF : 0.5192 (+0.44%)
QBIO : 3.4500 (-0.29%)
SNYR : 0.3350 (+4.69%)
ACBFF : 7.5300 (-4.32%)
CVSI : 1.6300 (+17.27%)
COSM : 6.1500 (+8.85%)
RSASF : 0.3020 (-22.44%)
GTBP : 2.0500 (+0.49%)
ZYXI : 3.1000 (-6.06%)
GRWG : 4.2700 (-0.47%)
PURE : 0.7000 (+16.67%)
CXDO : 2.7500 (+3.77%)
BCTXF : 0.1300 (+1.56%)
TAOIF : 0.3082 (+3.81%)
BNOEF : 0.3950 (+3.03%)
NMKEF : 0.6820 (+7.69%)
CNNRF : 4.0300 (-0.98%)
ITHUF : 5.6246 (-2.18%)
HEOFF : 0.9007 (-2.43%)
ZEST : 1.4500 (-3.33%)
COTQF : 0.3740 (-4.30%)
OTCM : 27.8100 (-3.34%)
DCTH : 2.8000 (+1.82%)
AEYE : 0.2310 (+0.43%)
TITXF : 0.1930 (-1.03%)
VFFIF : 5.6657 (-1.64%)
NMGRF : 0.2313 (+3.63%)
GLDLF : 0.6800 (+1.49%)
SNNVF : 5.9500 (+0.90%)
IWSY : 1.3100 (-0.76%)
ARTH : 0.4640 (+1.98%)
IRNC : 0.7000 (-23.08%)
PNGZF : 0.1650 (+13.79%)
NTSFF : 0.9154 (-1.71%)
GT Biopharma Announces $7.1 Million Convertible Debt Financing

LOS ANGELES , January 23, 2018 /PRNewswire/ --

GTBP : 2.0500 (+0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Strengthening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum. Long term indicators mostly agree with the trend.

See More Share

Trade GTBP with:

Key Turning Points

2nd Resistance Point 2.1233
1st Resistance Point 2.0867
Last Price 2.0500
1st Support Level 1.9767
2nd Support Level 1.9033

See More

52-Week High 36.9000
Fibonacci 61.8% 23.2588
Fibonacci 50% 19.0450
Fibonacci 38.2% 14.8312
Last Price 2.0500
52-Week Low 1.1900

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar